To differentiate cHCC-CC from ICC, Zhou et al. developed a combined clinical-radiomics model that incorporated clinical variables like serum AFP and background liver disease, such as cirrhosis or chronic hepatitis, along with an MRI radiomics model [94]. Here, AFP is linked to intrahepatic cholangiocarcinoma.